139 related articles for article (PubMed ID: 37898412)
1. A novel homozygous mutation in RASGRP1 that predisposes to immune dysregulation and immunodeficiency associated with uncontrolled Epstein-Barr virus-induced B cell proliferation.
Mansour R; El-Orfali Y; Saidu A; Al-Kalamouni H; Mardirossian H; Hanna-Wakim R; Abboud M; Massaad MJ
Clin Immunol; 2023 Dec; 257():109813. PubMed ID: 37898412
[TBL] [Abstract][Full Text] [Related]
2. Novel Mutations in RASGRP1 are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma.
Somekh I; Marquardt B; Liu Y; Rohlfs M; Hollizeck S; Karakukcu M; Unal E; Yilmaz E; Patiroglu T; Cansever M; Frizinsky S; Vishnvenska-Dai V; Rechavi E; Stauber T; Simon AJ; Lev A; Klein C; Kotlarz D; Somech R
J Clin Immunol; 2018 Aug; 38(6):699-710. PubMed ID: 30030704
[TBL] [Abstract][Full Text] [Related]
3. Combined immunodeficiency with EBV positive B cell lymphoma and epidermodysplasia verruciformis due to a novel homozygous mutation in RASGRP1.
Platt CD; Fried AJ; Hoyos-Bachiloglu R; Usmani GN; Schmidt B; Whangbo J; Chiarle R; Chou J; Geha RS
Clin Immunol; 2017 Oct; 183():142-144. PubMed ID: 28822832
[TBL] [Abstract][Full Text] [Related]
4. Loss of RASGRP1 in humans impairs T-cell expansion leading to Epstein-Barr virus susceptibility.
Winter S; Martin E; Boutboul D; Lenoir C; Boudjemaa S; Petit A; Picard C; Fischer A; Leverger G; Latour S
EMBO Mol Med; 2018 Feb; 10(2):188-199. PubMed ID: 29282224
[TBL] [Abstract][Full Text] [Related]
5. EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency.
Schipp C; Schlütermann D; Hönscheid A; Nabhani S; Höll J; Oommen PT; Ginzel S; Fleckenstein B; Stork B; Borkhardt A; Stepensky P; Fischer U
Front Immunol; 2018; 9():2400. PubMed ID: 30386345
[TBL] [Abstract][Full Text] [Related]
6. RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics.
Salzer E; Cagdas D; Hons M; Mace EM; Garncarz W; Petronczki ÖY; Platzer R; Pfajfer L; Bilic I; Ban SA; Willmann KL; Mukherjee M; Supper V; Hsu HT; Banerjee PP; Sinha P; McClanahan F; Zlabinger GJ; Pickl WF; Gribben JG; Stockinger H; Bennett KL; Huppa JB; Dupré L; Sanal Ö; Jäger U; Sixt M; Tezcan I; Orange JS; Boztug K
Nat Immunol; 2016 Dec; 17(12):1352-1360. PubMed ID: 27776107
[TBL] [Abstract][Full Text] [Related]
7. Compound heterozygous TYK2 mutations underlie primary immunodeficiency with T-cell lymphopenia.
Nemoto M; Hattori H; Maeda N; Akita N; Muramatsu H; Moritani S; Kawasaki T; Maejima M; Ode H; Hachiya A; Sugiura W; Yokomaku Y; Horibe K; Iwatani Y
Sci Rep; 2018 May; 8(1):6956. PubMed ID: 29725107
[TBL] [Abstract][Full Text] [Related]
8. RASGRP1 mutation in autoimmune lymphoproliferative syndrome-like disease.
Mao H; Yang W; Latour S; Yang J; Winter S; Zheng J; Ni K; Lv M; Liu C; Huang H; Chan KW; Pui-Wah Lee P; Tu W; Fischer A; Lau YL
J Allergy Clin Immunol; 2018 Aug; 142(2):595-604.e16. PubMed ID: 29155103
[TBL] [Abstract][Full Text] [Related]
9. NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation.
Boztug H; Hirschmugl T; Holter W; Lakatos K; Kager L; Trapin D; Pickl W; Förster-Waldl E; Boztug K
J Clin Immunol; 2016 Aug; 36(6):533-40. PubMed ID: 27338827
[TBL] [Abstract][Full Text] [Related]
10. When to suspect inborn errors of immunity in Epstein-Barr virus-related lymphoproliferative disorders.
Sacco KA; Notarangelo LD; Delmonte OM
Clin Microbiol Infect; 2023 Apr; 29(4):457-462. PubMed ID: 36209991
[TBL] [Abstract][Full Text] [Related]
11. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.
Latour S; Fischer A
Immunol Rev; 2019 Sep; 291(1):174-189. PubMed ID: 31402499
[TBL] [Abstract][Full Text] [Related]
12. A Novel STK4 Mutation Impairs T Cell Immunity Through Dysregulation of Cytokine-Induced Adhesion and Chemotaxis Genes.
Guennoun A; Bougarn S; Khan T; Mackeh R; Rahman M; Al-Ali F; Ata M; Aamer W; Prosser D; Habib T; Chin-Smith E; Al-Darwish K; Zhang Q; Al-Shakaki A; Robay A; Crystal RG; Fakhro K; Al-Naimi A; Al Maslamani E; Tuffaha A; Janahi I; Janahi M; Love DR; Karim MY; Lo B; Hassan A; Adeli M; Marr N
J Clin Immunol; 2021 Nov; 41(8):1839-1852. PubMed ID: 34427831
[TBL] [Abstract][Full Text] [Related]
13. Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases.
Latour S; Winter S
Front Immunol; 2018; 9():1103. PubMed ID: 29942301
[TBL] [Abstract][Full Text] [Related]
14. TET2 and LILRB1 mutations are frequent in Epstein-Barr virus-positive diffuse large B-cell lymphoma especially in elderly patients.
Cho J; Kim E; Yoon SE; Kim SJ; Kim WS
Cancer; 2023 May; 129(10):1502-1512. PubMed ID: 36812290
[TBL] [Abstract][Full Text] [Related]
15. Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency.
Abolhassani H; Edwards ES; Ikinciogullari A; Jing H; Borte S; Buggert M; Du L; Matsuda-Lennikov M; Romano R; Caridha R; Bade S; Zhang Y; Frederiksen J; Fang M; Bal SK; Haskologlu S; Dogu F; Tacyildiz N; Matthews HF; McElwee JJ; Gostick E; Price DA; Palendira U; Aghamohammadi A; Boisson B; Rezaei N; Karlsson AC; Lenardo MJ; Casanova JL; Hammarström L; Tangye SG; Su HC; Pan-Hammarström Q
J Exp Med; 2017 Jan; 214(1):91-106. PubMed ID: 28011864
[TBL] [Abstract][Full Text] [Related]
16. High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency.
Bienemann K; Borkhardt A; Klapper W; Oschlies I
Histopathology; 2015 Nov; 67(5):607-16. PubMed ID: 25728094
[TBL] [Abstract][Full Text] [Related]
17. SLP76 Mutation Associated with Combined Immunodeficiency and EBV-Related Lymphoma.
Lev A; Asleh M; Levy S; Lee YN; Simon AJ; Stepensky P; Nalbandyan K; Nahum A; Ben-Harosh M; Yablonski D; Broides A; Somech R
J Clin Immunol; 2023 Apr; 43(3):625-635. PubMed ID: 36474126
[TBL] [Abstract][Full Text] [Related]
18. Increased baseline RASGRP1 signals enhance stem cell fitness during native hematopoiesis.
Karra L; Romero-Moya D; Ksionda O; Krush M; Gu Z; Mues M; Depeille P; Mullighan C; Roose JP
Oncogene; 2020 Nov; 39(45):6920-6934. PubMed ID: 32989257
[TBL] [Abstract][Full Text] [Related]
19. Genetic Defects in Phosphoinositide 3-Kinase δ Influence CD8
Cannons JL; Preite S; Kapnick SM; Uzel G; Schwartzberg PL
Front Immunol; 2018; 9():1758. PubMed ID: 30116245
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation complicated with EBV associated hemophagocytic lymphohistiocytosis in a patient with DOCK2 deficiency.
Aytekin ES; Çağdaş D; Tan Ç; Çavdarlı B; Bilgiç I; Tezcan İ
Turk J Pediatr; 2021; 63(6):1072-1077. PubMed ID: 35023658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
